| Effects of rosiglitazone on cardiac function in CAPD patients: a tissue Doppler study. | |
| | |
MedLine Citation:
|
PMID: 19839823 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
BACKGROUND: Insulin resistance was an independent predictor of cardiovascular mortality in uremic patients without diabetes. Rosiglitazone (ROS) improves insulin sensitivity in the liver, muscle, and adipose tissue. We prospectively investigated the effects of ROS on cardiac functions by standard (SDE) and tissue Doppler echocardiography (TDI) in continuous ambulatory peritoneal dialysis (CAPD) patients. METHODS: A total of 24 CAPD patients (13 males, 11 females; mean age 42.2 +/- 14.8 years) were included. Routine blood samples were examined. Left and right ventricular functions were assessed, and myocardial performance index (MPI) was calculated by SDE and TDI at baseline and after 12-month ROS therapy. Left and right atrial volumes were measured and indexed to body surface area. RESULTS: When compared with baseline, after 12 months of ROS treatment, it was shown that early (E) and late (A) diastolic velocities of atrioventricular valves, E/A ratio, mitral E-wave deceleration time (DT), isovolumetric relaxation time (IVRT), and MPI were similar (p > 0.05). Also, no significant changes were detected in LV dimensions, LV mass index, LVEF, LA volume index, or RA volume index measured by SDE before and after ROS therapy (p > 0.05). Left and right ventricular function parameters measured by TDI including Sm, Em, Am, Em/Am ratio, E/Em ratio, and MPI were similar. CONCLUSION: It was found that there was no negative effect of long-term ROS therapy on cardiac functions measured by SDE and TDI in CAPD patients. |
| | |
Authors:
|
Ahmet Akcay; Gurkan Acar; Abdullah Sokmen; Gulizar Sokmen; Ekrem Dogan; Hayriye Sayarlioglu; Cagatay Citirik; Mehmet Ali Ucar; Cemal Tuncer |
Related Documents
:
|
10982543 - Echocardiographic characterization of cardiomyopathy in friedreich's ataxia with tissue... 19765073 - Association of left atrial strain and strain rate assessed by speckle tracking echocard... 15334573 - Time course of 23na signal intensity after myocardial infarction in humans. |
Publication Detail:
|
Type: Comparative Study; Journal Article |
Journal Detail:
|
Title: Renal failure Volume: 31 ISSN: 1525-6049 ISO Abbreviation: Ren Fail Publication Date: 2009 |
Date Detail:
|
Created Date: 2009-10-20 Completed Date: 2010-01-06 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 8701128 Medline TA: Ren Fail Country: England |
Other Details:
|
Languages: eng Pagination: 464-9 Citation Subset: IM |
Affiliation:
|
Faculty of Medicine, Department of Cardiology, Kahramanmaras Sutcu Imam University, Kahramanmaras, Turkey. dr.akcay@yahoo.com.tr |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adult Blood Flow Velocity Cohort Studies Echocardiography, Doppler, Pulsed / methods* Female Heart Function Tests Humans Kidney Failure, Chronic / diagnosis, mortality, therapy Male Middle Aged Peritoneal Dialysis, Continuous Ambulatory / adverse effects, methods* Probability Prognosis Prospective Studies Reference Values Risk Assessment Survival Analysis Thiazolidinediones / administration & dosage* Treatment Outcome Vasodilator Agents / administration & dosage* Ventricular Dysfunction, Left / drug therapy*, mortality, ultrasonography Ventricular Dysfunction, Right / drug therapy*, mortality, ultrasonography |
| Chemical | |
Reg. No./Substance:
|
0/Thiazolidinediones; 0/Vasodilator Agents; 122320-73-4/rosiglitazone |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Markers of tubular and glomerular injury in predicting acute renal injury outcome in thermal burn pa...
Next Document: Metabolic factors and microinflammatory state promote kidney injury in type 2 diabetes mellitus pati...